By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Teva Pharmaceutical Industries Limited 

5 Basel Street

Petach Tikva    49131  Israel
Phone: 972-3-9267-267 Fax: 972-3-9234-050



Company News
Pfallergan Makes Pfizer (PFE) Teva (TEVA)'s Largest Shareholder 11/25/2015 7:16:30 AM
Most Popular Big Pharma Stock in America is Israel's Teva (TEVA) 11/25/2015 6:44:35 AM
Heptares Lines Up a $410 Million Migraine Pact with Teva (TEVA) 11/25/2015 6:27:57 AM
Teva (TEVA) And University College London Embark On Unique Brain Imaging Study Aimed At Unlocking A New Approach In Neurodegenerative Disease 11/19/2015 10:58:15 AM
Teva (TEVA) Reports Positive Top-Line Results From Phase III Trials Evaluating Fluticasone Propionate/Salmeterol And Fluticasone Propionate Multidose Dry Powder Inhalers (Mdpis) In Patients With Asthma 11/19/2015 10:30:45 AM
Sources Reveal Glenmark Pharma, Sun Pharma (SUNPHARMA.NS), Cipla (CIPLA) are Exploring Bids Worth $500-800 Million for Teva (TEVA)'s Generics Products Portfolio 11/19/2015 6:54:02 AM
Teva (TEVA) To Present At The Jefferies Autumn 2015 Global Healthcare Conference 11/17/2015 10:49:09 AM
Teva (TEVA) Launches #Laugh4Lungs Social Media Campaign In Recognition Of World COPD Day 2015 11/11/2015 10:34:14 AM
Teva (TEVA) Snags Breakthrough Therapy Designation from the FDA for Huntington's Disease Drug 11/9/2015 8:19:56 AM
Teva (TEVA) To Present New Respiratory Data At The 2015 Annual Scientific Meeting Of The American College of Allergy, Asthma and Immunology (ACAAI) 11/4/2015 11:05:11 AM